Characteristics and Prognosis of Acquired Resistance to Immune Checkpoint Inhibitors in Gastrointestinal Cancer

IMPORTANCE: With the expanding use of immune checkpoint inhibitors (ICIs) in gastrointestinal (GI) cancer, the occurrence of acquired resistance (AR) has gradually emerged. However, the progression patterns and survival of patients with AR to ICIs are still unknown. OBJECTIVE: To explore the charact...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuo, Na, Liu, Chang, Zhang, Qi, Li, Jian, Zhang, Xiaotian, Gong, Jifang, Lu, Ming, Peng, Zhi, Zhou, Jun, Wang, Xicheng, Jiao, Xi, Wang, Yujiao, Wang, Yanni, Gao, Mengting, Shen, Lin, Lu, Zhihao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965636/
https://www.ncbi.nlm.nih.gov/pubmed/35348710
http://dx.doi.org/10.1001/jamanetworkopen.2022.4637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965636/
https://www.ncbi.nlm.nih.gov/pubmed/35348710
http://dx.doi.org/10.1001/jamanetworkopen.2022.4637

Ejemplares similares